Xortx Therapeutics
(NASDAQ) XRTX
Xortx Therapeutics Financials at a Glance
Market Cap
$2.85M
Revenue (TTM)
$0.00
Net Income (TTM)
$2.89M
EPS (TTM)
$-0.60
P/E Ratio
-0.68
Dividend
$0.00
Beta (Volatility)
0.30 (Low)
Dividend
$0.00
Beta (Volatility)
0.30 (Low)
Price
$0.41
Volume
49,786.499
Open
$0.41
Price
$0.41
Volume
49,786.499
Open
$0.41
Previous Close
$0.40
Daily Range
$0.37 - $0.43
52-Week Range
$0.36 - $1.41
Dividend
$0.00
Beta (Volatility)
0.30 (Low)
Price
$0.41
Volume
49,786.499
Open
$0.41
Previous Close
$0.40
Daily Range
$0.37 - $0.43
52-Week Range
$0.36 - $1.41
XRTX News
XRTX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Xortx Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
17
CEO
Allen Warren Davidoff, PhD
Website
www.xortx.comHeadquarters
Vancouver, BC T2P 4K9, CA
XRTX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-98%
Return on Capital
-1%
Return on Assets
-78%
Earnings Yield
-1.47%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.85M
Shares Outstanding
6.96M
Volume
49.79K
Short Interest
0.00%
Avg. Volume
146.31K
Financials (TTM)
Gross Profit
$156.53K
Operating Income
$4.55M
EBITDA
$4.39M
Operating Cash Flow
$3.87M
Capital Expenditure
$4.12
Free Cash Flow
$3.87M
Cash & ST Invst.
$1.18M
Total Debt
$51.07K
Xortx Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$40.56K
-59.7%
Gross Margin
0.00%
N/A
Market Cap
$2.85M
N/A
Market Cap/Employee
$1.43M
N/A
Employees
2
N/A
Net Income
$822.64K
-790.9%
EBITDA
$782.08K
-641.3%
Quarterly Fundamentals
Net Cash
$1.13M
-53.4%
Accounts Receivable
$109.81K
+523.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$51.07K
+31.8%
Return on Assets
-78.35%
N/A
Return on Invested Capital
-1.23%
N/A
Free Cash Flow
$978.26K
-9.9%
Operating Cash Flow
$978.26K
-10.4%